Purchases and Sales Made in Q1 2024 in Supernus Pharmaceuticals, Inc. (SUPN)
This table provides information about the institutional ownership of Supernus Pharmaceuticals, Inc. (SUPN) during Q1 2024. The information is specifically focused on institutions that hold shares of SUPERNUS PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-142K- 81.33% |
$3.85M - $4.99M
|
32.6K
$1.27M
|
|
|
May 14, 2024
Q1 2024
|
Epoch Investment Partners, Inc.
New York, NY |
SELL
|
- |
-144K- 41.6% |
$3.91M - $5.07M
|
202K
$7.89M
|
|
|
May 15, 2024
Q1 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-171K- 87.96% |
$4.64M - $6.03M
|
23.5K
$915K
|
|
|
May 14, 2024
Q1 2024
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-184K- 34.0% |
$5M - $6.48M
|
358K
$13.9M
|
|
|
May 15, 2024
Q1 2024
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-1.08M- 23.18% |
$29.2M - $37.9M
|
3.57M
$139M
|